In vitro and in vivo inhibitory effects of TLR4 agonist, glucopyranosyl lipid A (GLA), on allergic rhinitis caused by Japanese cedar pollen
Matsumoto, Koji, Kouzaki, Hideaki, Yamamoto, Sayuri, Kikuoka, Hirotaka, Tojima, Ichiro, Meulen, Jan H., Shimizu, Takeshi
Published in Allergy (Copenhagen) (01.02.2020)
Published in Allergy (Copenhagen) (01.02.2020)
Get full text
Journal Article
Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A
Lu, Hailing, Betancur, Alec, Chen, Michael, ter Meulen, Jan H.
Published in Frontiers in oncology (19.08.2020)
Published in Frontiers in oncology (19.08.2020)
Get full text
Journal Article
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1
Somaiah, Neeta, Block, Matthew S, Kim, Joseph W, Shapiro, Geoffrey I, Do, Khanh T, Hwu, Patrick, Eder, Joseph P, Jones, Robin L, Lu, Hailing, Ter Meulen, Jan H, Bohac, Chet, Chen, Michael, Hsu, Frank J, Gnjatic, Sacha, Pollack, Seth M
Published in Clinical cancer research (01.10.2019)
Published in Clinical cancer research (01.10.2019)
Get full text
Journal Article
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1
Mahipal, Amit, Ejadi, Samuel, Gnjatic, Sacha, Kim-Schulze, Seunghee, Lu, Hailing, ter Meulen, Jan H., Kenney, Richard, Odunsi, Kunle
Published in Cancer Immunology, Immunotherapy (01.07.2019)
Published in Cancer Immunology, Immunotherapy (01.07.2019)
Get full text
Journal Article
Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates
Govindarajan, Dhanasekaran, Meschino, Steven, Guan, Liming, Clements, David E, ter Meulen, Jan H, Casimiro, Danilo R, Coller, Beth-Ann G, Bett, Andrew J
Published in Vaccine (07.08.2015)
Published in Vaccine (07.08.2015)
Get full text
Journal Article
HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells
Wee, Edmund G., Ondondo, Beatrice, Berglund, Peter, Archer, Jacob, McMichael, Andrew J., Baltimore, David, ter Meulen, Jan H., Hanke, Tomáš
Published in Molecular therapy (01.02.2017)
Published in Molecular therapy (01.02.2017)
Get full text
Journal Article
Abstract 5919: Component-specific qPCR assays for characterization and identity testing of multigenome ZVex®, a dendritic cell-targeting lentiviral vector platform
Bajaj, Anshika, Lin, Tsai-Yu, Ngo, Lisa Y., Murphy, Michele, Kelley-Clarke, Brenna, Gombotz, Wayne R., Meulen, Jan H. ter, Berglund, Peter
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma
Halwani, Ahmad S., Panizo, Carlos, Isufi, Iris, Herrera, Alex F., Okada, Craig Y., Cull, Elizabeth H., Kis, Bela, Chaves, Jorge M., Bartlett, Nancy L., Ai, Weiyun, de la Cruz-Merino, Luis, Bryan, Locke J., Houot, Roch, Linton, Kim, Briones, Javier, Chau, Ian, von Keudell, Gottfried R., Lu, Hailing, Yakovich, Adam, Chen, Michael, Meulen JH, ter, Yurasov, Sergey, Hsu, Frank J., Flowers, Christopher R.
Published in Leukemia & lymphoma (21.03.2022)
Published in Leukemia & lymphoma (21.03.2022)
Get full text
Journal Article
Abstract 2505: Therapeutic efficacy of the ZVex™ and GLAAS™ platforms in a B16-F10/hCAIX melanoma mouse model
Campbell, David J., Reeves, Rebecca S., Flynn, Patrick A., Robbins, Scott H., Berglund, Peter, ter Meulen, Jan H.
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Effect of intratumoral (IT) injection of the toll-like receptor 4 (TLR4) agonist G100 on a clinical response and CD4 T-cell response locally and systemically
Seo, Yongwoo David, Zhou, Jing, Morse, Kevin, Patino, Jeremy, Mackay, Sean, Kim, Edward Y., Conrad, Ernest U., O'Malley, Ryan Blair, Cranmer, Lee D., Lu, Hailing, Hsu, Frank J., Xu, Yuexin, Loggers, Elizabeth Trice, Hain, Taylor, Pillarisetty, Venu Gopal, Kane, Gabrielle, Riddell, Stanley, ter Meulen, Jan H., Jones, Robin Lewis, Pollack, Seth
Published in Journal of clinical oncology (10.02.2018)
Published in Journal of clinical oncology (10.02.2018)
Get full text
Journal Article
Abstract 2817: DCVex(TM): A novel DC-targeted vector platform for cancer immunotherapy
Albershardt, Tina C., Tareen, Semih U., Odegard, Jared M., Campbell, David J., Flynn, Patrick, Robbins, Scott H., Berglund, Peter, Meulen, Jan H. ter
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Abstract 702: DCVex(TM): A novel integration-deficient lentivector technology that incorporates genetic and post-translational elements to target dendritic cells
Tareen, Semih U., Kelley-Clarke, Brenna, Nicolai, Christopher J., Slough, Megan M., Vin, Chintan D., Hoeven, Neal Van, Robbins, Scott H., Meulen, Jan H. ter, Berglund, Peter
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article